Bitcoin halving
What does that mean?
$2.79T
Total marketcap
$117.63B
Total volume
BTC 49.85%     ETH 15.30%
Dominance

Bayer Aktiengesellschaft BAYZF Stock

30.79 USD {{ price }} 0.016245% {{change_pct}}%
Exchange
Other OTC
Market Cap
30.25B USD
LOW - HIGH [24H]
30.79 - 30.8 USD
VOLUME [24H]
63.56K USD
{{ volume }}
P/E Ratio
0
Earnings per share
-3.24 USD

Bayer Aktiengesellschaft Price Chart

Bayer Aktiengesellschaft BAYZF Financial and Trading Overview

Bayer Aktiengesellschaft stock price 30.79 USD
Previous Close 55.89 USD
Open 56.67 USD
Bid 0 USD x 0
Ask 0 USD x 0
Day's Range 56.67 - 56.8 USD
52 Week Range 45.99 - 67.8 USD
Volume 77.96K USD
Avg. Volume 26.46K USD
Market Cap 56.06B USD
Beta (5Y Monthly) 1.184291
PE Ratio (TTM) 17.16012
EPS (TTM) -3.24 USD
Forward Dividend & Yield 2.66 (4.75%)
Ex-Dividend Date May 2, 2023
1y Target Est N/A

BAYZF Valuation Measures

Enterprise Value 90.38B USD
Trailing P/E 17.16012
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.1103467
Price/Book (mrq) 1.3655487
Enterprise Value/Revenue 1.79
Enterprise Value/EBITDA 7.919

Trading Information

Bayer Aktiengesellschaft Stock Price History

Beta (5Y Monthly) 1.184291
52-Week Change -12.019%
S&P500 52-Week Change 20.43%
52 Week High 67.8 USD
52 Week Low 45.99 USD
50-Day Moving Average 61.43 USD
200-Day Moving Average 57.36 USD

BAYZF Share Statistics

Avg. Volume (3 month) 26.46K USD
Avg. Daily Volume (10-Days) 12.25K USD
Shares Outstanding 982.42M
Float 982.39M
Short Ratio N/A
% Held by Insiders 0%
% Held by Institutions 42.65%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 2.4
Trailing Annual Dividend Yield 4.29%
5 Year Average Dividend Yield 424.00%
Payout Ratio 0.6472
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 6.01%
Operating Margin (ttm) 15.53%
Gross Margin 61.49%
EBITDA Margin 22.60%

Management Effectiveness

Return on Assets (ttm) 3.90%
Return on Equity (ttm) 7.76%

Income Statement

Revenue (ttm) 50.49B USD
Revenue Per Share (ttm) 51.39 USD
Quarterly Revenue Growth (yoy) -1.70%
Gross Profit (ttm) 31.85B USD
EBITDA 11.41B USD
Net Income Avi to Common (ttm) 3.04B USD
Diluted EPS (ttm) 3.31
Quarterly Earnings Growth (yoy) -33.80%

Balance Sheet

Total Cash (mrq) 7.98B USD
Total Cash Per Share (mrq) 8.12 USD
Total Debt (mrq) 43.3B USD
Total Debt/Equity (mrq) 105.56 USD
Current Ratio (mrq) 1.152
Book Value Per Share (mrq) 41.595

Cash Flow Statement

Operating Cash Flow (ttm) 4.27B USD
Levered Free Cash Flow (ttm) 3.46B USD

Profile of Bayer Aktiengesellschaft

Country United States
State N/A
City Leverkusen
Address Kaiser-Wilhelm-Allee 1
ZIP 51368
Phone 49 214 30 1
Website https://www.bayer.com
Industry Drug Manufacturers-General
Sector(s) Healthcare
Full Time Employees 101735

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases, as well as collaboration with Bicycle Therapeutics to develop bicyclic peptides. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.

Q&A For Bayer Aktiengesellschaft Stock

What is a current BAYZF stock price?

Bayer Aktiengesellschaft BAYZF stock price today per share is 30.79 USD.

How to purchase Bayer Aktiengesellschaft stock?

You can buy BAYZF shares on the Other OTC exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Bayer Aktiengesellschaft?

The stock symbol or ticker of Bayer Aktiengesellschaft is BAYZF.

Which industry does the Bayer Aktiengesellschaft company belong to?

The Bayer Aktiengesellschaft industry is Drug Manufacturers-General.

How many shares does Bayer Aktiengesellschaft have in circulation?

The max supply of Bayer Aktiengesellschaft shares is 982.42M.

What is Bayer Aktiengesellschaft Price to Earnings Ratio (PE Ratio)?

Bayer Aktiengesellschaft PE Ratio is now.

What was Bayer Aktiengesellschaft earnings per share over the trailing 12 months (TTM)?

Bayer Aktiengesellschaft EPS is -3.24 USD over the trailing 12 months.

Which sector does the Bayer Aktiengesellschaft company belong to?

The Bayer Aktiengesellschaft sector is Healthcare.